Pascal Deschatelets
Founder presso APELLIS PHARMACEUTICALS, INC.
Patrimonio netto: 66 M $ in data 31/03/2024
Profilo
Pascal Deschatelets è un imprenditore che ha fondato Apellis Pharmaceuticals, Inc., Potentia Pharmaceuticals, Inc., Revon Systems, Inc. e Syntetica Fine Chemicals. Attualmente ricopre la posizione di direttore scientifico presso Apellis Pharmaceuticals, Inc. È anche nel consiglio di amministrazione di Revon Systems, Inc. Pascal Deschatelets ha precedentemente ricoperto la posizione di direttore operativo per Potentia Pharmaceuticals, Inc. Ha ricevuto un dottorato dall'Università di Montreal.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 08/04/2024 | 1 115 983 ( 0.93% ) | 66 M $ | 31/03/2024 |
Posizioni attive di Pascal Deschatelets
| Società | Posizione | Inizio |
|---|---|---|
| APELLIS PHARMACEUTICALS, INC. | Founder | 25/09/2009 |
Revon Systems, Inc.
 Revon Systems, Inc. Packaged SoftwareTechnology Services Revon Systems, Inc. operates a platform that connects physicians and patients for medicine. Its products include Revon Patient App, Revon Physician App, Alexa Skill and Research Coordinators Portal. The firm's platform’s digital interface supports data collection for the investigation of the performance of pharmaceutical and other interventions in various patient populations. It enables digital registry services, real world evidence collection and patient reported outcomes tracking for pharmaceutical and medical device companies conducting clinical trials. The company was founded by Cedric Francois and Pascal Deschatelets and is headquartered in Crestwood, KY. | Founder | - |
Precedenti posizioni note di Pascal Deschatelets
| Società | Posizione | Fine |
|---|---|---|
Potentia Pharmaceuticals, Inc.
 Potentia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Potentia Pharmaceuticals, Inc. operates as a biotechnology company. It focuses on the development of novel therapeutics and drug delivery technologies to address chronic inflammatory diseases. The company was founded by Cedric Francois, David Darst, Alec Machiels and Pascal Deschatelets in 2001 and is headquartered in Crestwood, KY. | Founder | 01/09/2016 |
| Syntetica Fine Chemicals | Founder | - |
Formazione di Pascal Deschatelets
| University of Montréal | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| APELLIS PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Potentia Pharmaceuticals, Inc.
Potentia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Potentia Pharmaceuticals, Inc. operates as a biotechnology company. It focuses on the development of novel therapeutics and drug delivery technologies to address chronic inflammatory diseases. The company was founded by Cedric Francois, David Darst, Alec Machiels and Pascal Deschatelets in 2001 and is headquartered in Crestwood, KY. | Health Technology |
Revon Systems, Inc.
Revon Systems, Inc. Packaged SoftwareTechnology Services Revon Systems, Inc. operates a platform that connects physicians and patients for medicine. Its products include Revon Patient App, Revon Physician App, Alexa Skill and Research Coordinators Portal. The firm's platform’s digital interface supports data collection for the investigation of the performance of pharmaceutical and other interventions in various patient populations. It enables digital registry services, real world evidence collection and patient reported outcomes tracking for pharmaceutical and medical device companies conducting clinical trials. The company was founded by Cedric Francois and Pascal Deschatelets and is headquartered in Crestwood, KY. | Technology Services |
| Syntetica Fine Chemicals |
- Borsa valori
- Insiders
- Pascal Deschatelets
